Zentiva Invests €27m In Prague Plant
Expansion Of Flagship Facility Follows €35m Investment Over Past Three Years
Zentiva has announced that it is investing a further €27m in expanding its flagship manufacturing plant in Prague, having already pumped €35m into the site over the past three years.
You may also be interested in...
Zentiva is opening a dedicated Indian office in Mumbai to support the Ankleshwar manufacturing facility that it has just acquired from former parent company Sanofi.
Alvogen’s central and eastern European business, which started up in 2010, has now been sold to the Zentiva group. Zentiva plans to combine both companies’ branded generics and OTC businesses in the CEE region.
Zentiva has announced it is buying the UK’s Creo Pharmaceuticals from Amneal Pharmaceuticals as it pursues its goal of becoming a European generics leader.